Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. LIVN
  6. >
  7. Earnings
stocks logo

LIVN Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of LivaNova PLC(LIVN) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of LivaNova PLC earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
FY2025Q32025-11-05Pre-Market0.781.11+42.31342.32M357.80M+4.52-5.80-5.67
FY2025Q22025-08-06Pre-Market0.721.05+45.83332.21M352.50M+6.11+11.15+16.31
FY2025Q12025-05-07Pre-Market0.630.88+39.68302.37M316.90M+4.81+23.72+28.64
FY2024Q42025-02-25Pre-Market0.670.81+20.90324.11M321.80M-0.71-15.76-15.72
FY2024Q32024-10-30Pre-Market0.560.90+60.71300.45M318.10M+5.88-3.08-6.19
FY2024Q22024-07-31-0.660.81+22.73305.24M318.60M+4.38-3.70-10.68
FY2024Q12024-05-01-0.450.73+62.22278.19M294.90M+6.01+12.32+13.22
FY2023Q42024-02-21-0.790.87+10.13287.70M310.10M+7.79+8.02+6.27
FY2023Q32023-11-01-0.620.73+17.74271.86M286.10M+5.24+2.02-3.16
FY2023Q22023-07-26-0.580.78+34.48265.04M293.90M+10.89+9.87+9.29
AI Stock Picker
AI Stock Picker

LIVN Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, LivaNova PLC reported performance for FY2025Q3, announced on 2025-11-05. The company achieved an EPS of 1.11, compared to analyst estimates of 0.78 by 42.31% . Revenue for the quarter reached 357.80M compared to expectations of 342.32M by 4.52% .
The stock price reacted with a -5.80% one-day change and a -5.67% five-day change following the earnings release. These movements reflect market reaction in LivaNova PLC growth trajectory and strategic initiatives.

LIVN Earnings Forecast

Looking ahead, LivaNova PLC(LIVN) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 353.52M and an EPS of 0.81.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.81%, while EPS estimates have been Revise Upward by 2.78%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Downward by -1.04% . These revisions correlate with a 10.23% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in LivaNova PLC long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between LIVN's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.81%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+2.78%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Downward
down Image
-1.04%
In Past 3 Month
Stock Price
Go Up
up Image
+10.23%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:1.38B
--
EPS Estimate-Annual FY 2025:3.86
—
Stock Price63.90
Intellectia AI SwingMax
Intellectia AI SwingMax

LIVN Revenue and EPS Performance: A Historical Perspective

LivaNova PLC revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-05,Pre-Market):
EPS: 1.11 (Actual) vs.0.78 (Estimate) (42.31%)
Revenue: 357.80M (Actual) vs. 342.32M (Estimate) (4.52%)
Price Reaction: -5.80%(1-Day), -5.67%(5-Day)
FY2025Q2 (2025-08-06,Pre-Market):
EPS: 1.05 (Actual) vs.0.72 (Estimate) (45.83%)
Revenue: 352.50M (Actual) vs. 332.21M (Estimate) (6.11%)
Price Reaction: 11.15%(1-Day), 16.31%(5-Day)
FY2025Q1 (2025-05-07,Pre-Market):
EPS: 0.88 (Actual) vs.0.63 (Estimate) (39.68%)
Revenue: 316.90M (Actual) vs. 302.37M (Estimate) (4.81%)
Price Reaction: 23.72%(1-Day), 28.64%(5-Day)
Earnings Reaction
The chart below shows how LIVN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, LIVN sees a -2.46% change in stock price 10 days leading up to the earnings, and a -0.56% change 10 days following the report. On the earnings day itself, the stock moves by +3.88%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -2.44% on the day following the earnings release and then changed by 6.10% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Financial AI Agent
Financial AI Agent

Transcript Summary

LivaNova PLC (LIVN) Q3 2025 Earnings Call Summary
Positive
2025-11-05
The earnings call presents a positive outlook with raised guidance for revenue growth, EPS, and free cash flow. The Q&A section highlights strategic investments in capacity expansion and new product launches, despite some conservative Q4 guidance. The positive feedback on the Essenz launch in China and the anticipated Medicare reimbursement increase for epilepsy therapy further support a positive sentiment. Although management avoided some specifics, the overall sentiment is positive, considering the strategic initiatives and growth prospects.
LivaNova PLC (LIVN) Q2 2025 Earnings Call Summary
Positive
2025-08-06
The earnings call reveals strong financial performance with increased operating income, EPS, and cash balance, alongside reduced debt. Product developments, like epilepsy treatment data and Essenz launch in China, are promising. CMS proposal and APC upgrade suggest potential reimbursement boosts. Despite some management vagueness in Q&A, the overall sentiment is positive, supported by growth drivers in cardiopulmonary and neuromodulation businesses. Thus, the stock is likely to experience a positive movement.
LivaNova PLC (LIVN) Q4 2024 Earnings Call Summary
Positive
2025-02-25
The earnings report shows strong revenue growth both quarterly and annually, improved operating income, and significant free cash flow growth. However, the decrease in EPS due to a higher tax rate and increased debt from a convertible note offering are concerns. The Q&A highlighted optimism in new product launches and strategic innovations, although some execution issues were noted. Overall, the positive financial performance and promising product developments outweigh the negatives, suggesting a positive stock price movement.
LivaNova PLC (LIVN) Q3 2024 Earnings Call Summary
Positive
2024-10-30
The earnings call summary shows strong financial performance with a revenue increase of 11%, strong cardiopulmonary and epilepsy revenue growth, and improved operating income margins. The shareholder return plan includes a significant share repurchase. The Q&A session did not reveal major concerns, though there was some uncertainty about future growth expectations. Overall, the positive financial metrics and strategic initiatives suggest a positive stock price movement over the next two weeks.
LivaNova PLC (LIVN) Q2 2024 Earnings Call Summary
Positive
2024-07-31
The earnings call reveals strong financial performance with 12% revenue growth, improved operating income margins, and increased free cash flow. Despite a slight decrease in gross margins, the company shows solid growth in key segments and strategic focus on innovation. The Q&A section indicates cautious optimism, with management addressing potential risks and uncertainties. The guidance suggests continued growth, and the share repurchase is a positive shareholder return signal. Overall, the sentiment is positive, with potential for a 2% to 8% stock price increase in the next two weeks.

People Also Watch

FAQ

arrow icon

What were the key highlights of LIVN’s latest earnings report for FY2025Q3?

LIVN reported its FY2025Q3 earnings on 2025-11-05, showcasing a revenue of 357.80M against an estimate of 342.32M, resulting in a 4.52% surprise. The EPS was 1.11, surpassing the expected 0.78 by 42.31% . The stock experienced a -5.8% price change on the earnings day and a -5.67% change over the next five days, reflecting market reactions to the results.
arrow icon

How did LIVN’s stock price react after the FY2025Q3 earnings release?

Following LIVN’s FY2025Q3 earnings announcement on 2025-11-05, the stock price moved by -5.80% on the day of the release. Over the subsequent five days, it saw a -5.67% change. Historically, LIVN’s stock price tends to shift by an average of -2.46% in the 10 days leading up to earnings and -0.56% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for LIVN for 2025/Q4?

For 2025/Q4, analysts estimate LIVN’s annual revenue to reach 353.52M, while the EPS is projected at 0.81. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.81% and EPS estimates Revise Downward by -1.04% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does LIVN’s stock price correlate with earnings forecast revisions?

The correlation between LIVN’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.81%, while EPS estimates moved Revise Downward by -1.04% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from LIVN’s next earnings report?

Based on historical trends, LIVN’s stock price typically moves by -2.46% in the 10 days before its earnings and -0.56% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.81 and revenue of 353.52M.
arrow icon

What is the sentiment in LivaNova PLC (LIVN) Q3 2025 Earnings Call Summary?

The earnings call presents a positive outlook with raised guidance for revenue growth, EPS, and free cash flow. The Q&A section highlights strategic investments in capacity expansion and new product launches, despite some conservative Q4 guidance. The positive feedback on the Essenz launch in China and the anticipated Medicare reimbursement increase for epilepsy therapy further support a positive sentiment. Although management avoided some specifics, the overall sentiment is positive, considering the strategic initiatives and growth prospects.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free